All News #Library
Biotech
Cipla Introduces Ciplostem Cell Therapy For Knee Osteoarthritis
06 Dec 2025 //
EXPRESSPHARMA
MEDINET, Stempeutics Ink Stempeucel Option License in Japan
27 Oct 2025 //
EXPRESSPHARMA
Phase 3 Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published
23 Aug 2023 //
BUSINESSWIRE

Market Place
Sourcing Support